wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

B. pharma

Total questions: 23

Worksheet time: 12mins

Name
Class
Date
1.

how many subjects must participate in phase 1 testing to be considered as valid?

a)

100-200

b)

20-100

c)

50-200

d)

20-100

2.

which phase of clinical testing gives an information about the efficacy of new drug?

a)

l

b)

ll

c)

lll

d)

l and ll

e)

ll and lll

3.

which phase of clinical trial is responsible for drug safety?

a)

l

b)

ll

c)

lll

d)

l and ll

e)

l and lll

4.

how many years after filing the application does patent of the drug expire?

a)

5

b)

10

c)

15

d)

20

5.

what does "no- effect dose" stands for?

a)

the dose that kills approximately 50% of the animals

b)

the smallest dose that is observed to kill any experimental animal

c)

the maximum dose at which a specified toxic effect is not seen

6.

which phase of the clinical trial is acceptable to be open or nonblind?

a)

l

b)

ll

c)

lll

d)

l and lll

7.

which phase of the clinical trial MUST be double blind?

a)

l

b)

ll

c)

lll

d)

ll and lll

8.

what is the primary purpose of phase 2 clinical trials?

a)

to assess the safety of the drug

b)

to evaluate the efficacy of the drug

c)

to determine the optimal dosage

d)

to monitor long-term effects

9.

which phase of clinical trials typically involves the largest number of participants?

a)

l

b)

ll

c)

lll

d)

l and ll

10.

what is the main focus of phase 3 clinical trials?

a)

to test the drug on healthy volunteers

b)

to compare the new drug with standard treatments

c)

to identify side effects in a small group

d)

to establish the drug's mechanism of action

11.

what is the primary goal of phase 1 clinical trials?

a)

to evaluate the drug's safety

b)

to determine the drug's efficacy

c)

to assess the drug's long-term effects

d)

to compare the drug with existing treatments

12.

which phase of clinical trials is typically the first to involve patients?

a)

l

b)

ll

c)

lll

d)

l and ll

13.

what is the significance of a placebo in clinical trials?

a)

to provide a control group for comparison

b)

to enhance the drug's effectiveness

c)

to ensure patient compliance

d)

to identify side effects

14.

which part of pharmacology is responsible for absorption, metabolism, elimination, distribution

a)

pharmacodynamics

b)

pharmacokinetics

c)

pharmacogenomics

15.

what is the main purpose of phase 4 clinical trials?

a)

to monitor long-term effects of the drug

b)

to evaluate the drug's safety in a larger population

c)

to compare the drug with other treatments

d)

to determine the drug's mechanism of action

16.

what is the primary focus of pharmacodynamics?

a)

the study of drug absorption

b)

the study of drug effects on the body

c)

the study of drug interactions

17.

which regulatory body is responsible for approving new drugs in the United States?

a)

FDA

b)

EMA

c)

WHO

d)

CDC

18.

what is the main purpose of phase 3 clinical trials?

a)

to assess the drug's safety

b)

to evaluate the drug's efficacy in a larger population

c)

to determine the optimal dosage

d)

to monitor long-term effects

19.

what is the typical duration of phase 1 clinical trials?

a)

3-5 years

b)

6-12 months

c)

1-2 years

d)

1-2 months

20.

what is the primary focus of phase 4 clinical trials?

a)

to monitor the drug's long-term safety and effectiveness

b)

to determine the drug's optimal dosage

c)

to assess the drug's interactions with other medications

d)

to evaluate the drug's effects on specific populations

21.

what is the role of a control group in clinical trials?

a)

to enhance patient recruitment

b)

to provide a baseline for comparison

c)

to ensure the drug's effectiveness

d)

to monitor adverse reactions

22.

which phase of clinical trials is primarily concerned with post-marketing surveillance?

a)

l

b)

lV

c)

ll

d)

lll

23.

what is the significance of randomization in clinical trials?

a)

to reduce the number of participants needed

b)

to enhance the drug's effectiveness

c)

to ensure equal distribution of characteristics among groups

d)

to monitor long-term effects